| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/17/2002 | EP1049670B1 Azetidinecarboxamide derivatives for treating cns disorders |
| 07/17/2002 | EP1042353B1 17beta-aryl (arylmethyl) oxy(thio)alkyl -androstane derivatives |
| 07/17/2002 | EP1042327A4 A process for the reduction of oxiranyl epothilones to olefinic epothilones |
| 07/17/2002 | EP1039902A4 Inhibitors of gap junction communication |
| 07/17/2002 | EP1023034B1 Cosmetic formulations for the prevention and therapy of hair loss |
| 07/17/2002 | EP1017392B1 Medicament formulation with a controlled release of an active agent |
| 07/17/2002 | EP1007086B1 Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating helicobacter pylori infection |
| 07/17/2002 | EP0979224B1 Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine magnesium fumarate |
| 07/17/2002 | EP0978281B1 Eyedrops containing a loratidine metabolite |
| 07/17/2002 | EP0967968B1 Pharmaceutical or cosmetic composition containing at least one retinoid and melibiose |
| 07/17/2002 | EP0963195B1 Compositions containing an antifungal and a cationic agent |
| 07/17/2002 | EP0939629A4 Thiol sulfonamide metalloprotease inhibitors |
| 07/17/2002 | EP0925278B1 Cytostatic hydroxamic acid derivatives |
| 07/17/2002 | EP0915857B1 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetics and pharmaceuticals |
| 07/17/2002 | EP0901492B1 Taxane derivatives, the preparation thereof and formulations containing them |
| 07/17/2002 | EP0888340B1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 07/17/2002 | EP0888298B1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 07/17/2002 | EP0882044B1 1,4-dihydropyridine compounds as bradykinin antagonists |
| 07/17/2002 | EP0876398B1 Induction of immune response against desired determinants |
| 07/17/2002 | EP0871638B1 Novel aminooligosaccharide derivative and process for preparing the same |
| 07/17/2002 | EP0866709A4 1,2,4-benzotriazine oxides formulations |
| 07/17/2002 | EP0863753B1 Use of perfluoroalkyl derivatives of amino acids as metallo-beta-lactamase inhibitors |
| 07/17/2002 | EP0851865B1 12H-Dibenzo[d,g][1,3]dioxocine derivatives |
| 07/17/2002 | EP0842662B1 Percutaneous tape preparation containing fentanyl |
| 07/17/2002 | EP0828494B1 Method for treating cognitive dysfunction |
| 07/17/2002 | EP0823254B1 Novel use of pyrazolopyridine compounds |
| 07/17/2002 | EP0817637B1 Synergistic combinations of zidovudine, 1592u89 and 3tc |
| 07/17/2002 | EP0801568B1 Compounds for inhibition of ceramide-mediated signal transduction |
| 07/17/2002 | EP0766668B1 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof |
| 07/17/2002 | EP0755246B1 Ophthalmic composition containing an ion sensitive, hydrophilic polymer and an inorganic salt in a ratio which gives low viscosity |
| 07/17/2002 | EP0749452B1 Polymer-conjugated malonic acid derivatives and their use as medicaments and diagnostic agents |
| 07/17/2002 | EP0735862B1 Method for dry blend compression of medicaments |
| 07/17/2002 | EP0694035B1 Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents |
| 07/17/2002 | EP0686156B1 Pyrazolitriazines with interleukin-1 and tumour necrosis factor inhibitory activity |
| 07/17/2002 | EP0598061B1 Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents |
| 07/17/2002 | CN1359469A Epitopes formed by non-covalent association of conjugates |
| 07/17/2002 | CN1359389A Substantially crystalline form of melagatran |
| 07/17/2002 | CN1359386A Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines |
| 07/17/2002 | CN1359384A Taxane derivatives and processes for the preparation thereof |
| 07/17/2002 | CN1359383A Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process |
| 07/17/2002 | CN1359382A Method for preparing citalopram |
| 07/17/2002 | CN1359381A Thiazole-derivaties |
| 07/17/2002 | CN1359380A Diaminothiazoles and their use for inhibiting protein kinases |
| 07/17/2002 | CN1359378A 2-oxy-benzoxazine derivatives for the treatment of obesity |
| 07/17/2002 | CN1359377A Dihydrobenzodiazepins and their use for treating dyslipidemia |
| 07/17/2002 | CN1359376A Carboxylic acid derivatives compriosing aryl-substituted nitrogen heterocycles, their production and their use as endothel in receptor antagonists |
| 07/17/2002 | CN1359375A Novel piperazinylalkyl thiopyrimidine derivatives, pharmaceutical compositions containing the same, and a process for the preparation of same |
| 07/17/2002 | CN1359373A 6[(aryl and heteroaryl)oxy] methyl] naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof |
| 07/17/2002 | CN1359371A Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 07/17/2002 | CN1359370A Esters of L-carnitine or alkanoyl L-carnitines |
| 07/17/2002 | CN1359303A Pharmaceutical complex |
| 07/17/2002 | CN1359302A Remedies for immunoogical diseases |
| 07/17/2002 | CN1359297A Method for preventing tumoral growth |
| 07/17/2002 | CN1359295A Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug |
| 07/17/2002 | CN1359294A Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel |
| 07/17/2002 | CN1359293A Pharmaceutical compositions comprising dipeptidy peptidase in inhibitors for the promotion of growth |
| 07/17/2002 | CN1359291A Aminoethanesulfonic acid-containing preparations |
| 07/17/2002 | CN1359290A Medicinal compositions for preventing or treating viral myocarditis |
| 07/17/2002 | CN1359289A Selective iGLuR5 receptor antagonists for the treatment of migraine |
| 07/17/2002 | CN1359288A Method for improvement of transport across adaptable semi-permeable barriers |
| 07/17/2002 | CN1359287A Cosmetic skin care compositions containing cumic alcohol |
| 07/17/2002 | CN1359285A Topically applied idebenone-containing agent with protective and regenerative effect |
| 07/17/2002 | CN1359262A Therapeutic anti-fungal nail preparation |
| 07/17/2002 | CN1358734A 5 alpha, 8 alpha-epidioxy-24-dimethycholestane-6-alkene-three beta-alcohol and its heterosides and ester preparation process and use |
| 07/17/2002 | CN1358730A Oligose capable of being used as medicine and its surfated products and preparation process thereof, and medicinal composition having same |
| 07/17/2002 | CN1358723A Novel bicyclic amino-pyrazino ketone compound, its preparation method and medicinal composition having same |
| 07/17/2002 | CN1358720A Three-site substituted beta-carboline novel compound having anti-HIV and anti-cancer activity |
| 07/17/2002 | CN1358716A Substituted benzopyran anti-fungus compound |
| 07/17/2002 | CN1358539A Ointment for treating ulcer and hyperplastic skin and preparation process |
| 07/17/2002 | CN1358534A Compound medicine for treating bronchial asthma and preparation process |
| 07/17/2002 | CN1358524A Spraying medicine for treating tinea pedis and process for making same |
| 07/17/2002 | CN1358518A Compound and powder prescription |
| 07/17/2002 | CN1358505A Capsule for treating headache |
| 07/17/2002 | CN1358499A Animal phisiologicla and biological activity regulation agent composition containing cysteamine and its salt |
| 07/17/2002 | CN1358494A Composition for increasing osmosis of local skin reagent |
| 07/17/2002 | CN1087741C New indole and inidazole compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/17/2002 | CN1087740C New benzimidzole, benzoxazole and benzothiazole compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/17/2002 | CN1087739C Inclusion and resolution preparation process of optical purity benzimidazoles medicines resisting peptic ulcer |
| 07/17/2002 | CN1087737C Dihygropyridine derivatives as bradykinin ant agonists |
| 07/17/2002 | CN1087736C Novel amidinonaphthyl derivative or salt thereof |
| 07/17/2002 | CN1087725C Enhancement of the effect of drugs by deuteration |
| 07/17/2002 | CN1087621C Ointment for treating burn and scald |
| 07/17/2002 | CN1087613C Pharmaceutical preparations having antithrombotic activity and process for preapring same |
| 07/17/2002 | CN1087611C Oral nutrient lead-expelling powdered granules |
| 07/17/2002 | CN1087610C Lentinus edodes polysaccharide injecta and its preparation |
| 07/17/2002 | CN1087609C Chalcones and esters thereof with antiproliferative activity ini uterus, ovary and breast tumours |
| 07/17/2002 | CN1087608C Use of dicafeoyl quininic acid in treatment of hepatitis B and diseases associated with retrovirus and cafeoyl quininic acid derivs |
| 07/16/2002 | US6420604 Process for the acylation of amino alcohols |
| 07/16/2002 | US6420600 Hydroxyalkylphenyldiamides |
| 07/16/2002 | US6420591 Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection |
| 07/16/2002 | US6420574 Reacting 1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile with substituted alkyl halide/sulfonate; chemical intermediate converted to amine; antidepressant; avoids by-product formation |
| 07/16/2002 | US6420572 Flavanoid derivatives and phenolic derivatives with halogenation |
| 07/16/2002 | US6420570 Psoralen compounds |
| 07/16/2002 | US6420568 Compounds for antifibrillatory and antiarrhythmic agents. the processes of this invention are useful for making |
| 07/16/2002 | US6420567 Prodrugs |
| 07/16/2002 | US6420561 Piperazinyl or piperidinyl acid derivatives for treatment of rheumatic diseases, arthritis due to gout and antiinflammatory agents |
| 07/16/2002 | US6420559 1-(4-arylpiperazin-1-yl)-ω-[N-(α,ω-dicarboximido)]-alkanes useful as uro-selective α1-adrenoceptor blockers |
| 07/16/2002 | US6420557 For therapy of male erectile dysfunction |
| 07/16/2002 | US6420554 Process for preparation of 3-cephem compound |
| 07/16/2002 | US6420551 Antisense oligonucleotides targeted against human immunodeficiency virus |